Cardiofront Logo
Jafib Logo
St. Jude Medical

July 29th, 2014
Submit Manuscript
AF Literature Database
Search Knowledgebase by
Author Last name starts with
B. Weijs(4)Alan S. Go, MD(3)Charlotte Eitel, MD(3)
Ayman A. Hussein, MD(3)Asirvatham Samuel J SJ(3)Chao TF(2)
Chen Peng-Sheng PS(2)Andrade JG(2)Akira Fukui, MD(2)
Albert Nancy M NM(2)Ajay K Jain(2)Cook G Elliott GE(2)
Botto GL(2)Casella M(2)Bokeriia L A LA(2)
Antonio Hernández-Madrid(2)Christian Sohns(2)Bengt Zöller(2)
Badger Troy J TJ(2)Charlotte Eitel(2)Blanke Philipp P(2)
Anné Wim W(2)Chamberlain AM(2)Berenfeld Omer O(2)
Caputo M(2)Andreas Goette1(1)Anand N. Ganesan, MBBS, PhD(1)
Aguadé-Bruix Santiago S(1)Akhmedov V A VA(1)Arepally Gowthami G(1)
Alcaraz Raúl R(1)Chugh Aman A(1)Bai W(1)
Claudia Lerma(1)Bhatia Nisha L NL(1)Brabant G G(1)
Chu Zhi-Gang ZG(1)Ad Niv N(1)Chan Chin Pang CP(1)
Aliot E E(1)Cooper Jonas A JA(1)Albini Adriana A(1)
Bodenmann Patrick P(1)Belchikov Yuly G YG(1)Bruce D. Nearing, PhD(1)
Barry Michael M(1)Collerton Joanna J(1)Brüggenjürgen B B(1)
Aizawa Yoshiyasu Y(1)Alpert Joseph S JS(1)
Literature Related to Edvardsson NG [Author]
[1]
Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery?
Authors : Heidarsdottir Ragnhildur R; Arnar David O DO; Skuladottir Gudrun V GV; Torfason Bjarni B; Edvardsson Vidar V; Gottskalksson Gizur G; Palsson Runolfur R; Indridason Olafur S OS;
Affiliation : Department of Physiology, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
Journal : Europace   (2010)
Related Links: Pubmed | Publisher website
Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options—a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference
Authors :
Affiliation : Tel: +49 251 8345185; fax: +49 251 8345185, Email: kirchhp@uni-muenster.de
Journal : N/A   (2011)
Related Links: Pubmed | Publisher website
Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery?
Authors : Heidarsdottir R; Arnar DO; Skuladottir GV; Torfason B; Edvardsson V; Gottskalksson G; Palsson R;
Affiliation : Division of Nephrology, Landspitali University Hospital, Office 14-F, Hringbraut, 101 Reykjavik, Iceland. Tel: +354 543 1000; fax: +354 543 4806. E-mail address: olasi@landspitali.is
Journal : EP Europace   (2010)
Related Links: Pubmed | Publisher website
Pharmacological cardioversion of atrial fibrillation—a double-blind, randomized, placebo-controlled, multicentre, dose-escalation study of AZD1305 given intravenously
Authors : Rónaszéki A; Alings M; Egstrup K; Gaciong Z; Hranai M; Király C; Sereg M; Figatowski W; Bondarov P; Johansson S; Frison L; Edvardsson N;
Affiliation : Department of Cardiology, Péterfy Hospital, Budapest, Hungary. Tel: +46 31 776 1000; fax: +46 31 776 3737 Email: anders.r.berggren@astrazeneca.com
Journal : Eurpopace   (2011)
Related Links: Pubmed | Publisher website
Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference.
Authors : Kirchhof P; Lip GY; Van Gelder IC; Bax J; Hylek E; Kaab S; Schotten U; Wegscheider K; Boriani G; Brandes A; Ezekowitz M; Diener H; Haegeli L; Heidbuchel H; Lane D; Mont L; Willems S; Dorian P; Aunes-Jansson M; Blomstrom-Lundqvist C; Borentain M; Breitenstein S; Brueckmann M; Cater N; Clemens A; Dobrev D; Dubner S; Edvardsson NG; Friberg L; Goette A; Gulizia M; Hatala R; Horwood J; Szumowski L; Kappenberger L; Kautzner J; Leute A; Lobban T; Meyer R; Millerhagen J; Morgan J; Muenzel F; Nabauer M; Baertels C; Oeff M; Paar D; Polifka J; Ravens U; Rosin L; Stegink W; Steinbeck G; Vardas P; Vincent A; Walter M; Breithardt G;
Affiliation : University Hospital Münster, Münster, Germany. Corresponding author. Tel: +49 251 8345185; fax: +49 251 8345185, Email: kirchhp@uni-muenster.de
Journal : Europace   (2011)
Related Links: Pubmed | Publisher website
Pharmacological cardioversion of atrial fibrillation—a double-blind, randomized, placebo-controlled, multicentre, dose-escalation study of AZD1305 given intravenously
Authors : Rónaszéki A; Alings M; Egstrup K; Gaciong Z; Hranai M; Király C; Sereg M; Figatowski W; Bondarov P; Johansson S; Frison L; Edvardsson N;
Affiliation : Department of Cardiology, Péterfy Hospital, Budapest, Hungary. Corresponding author. Tel: +46 31 776 1000; fax: +46 31 776 3737, Email: anders.r.berggren@astrazeneca.com
Journal : EP Europace   (2011)
Related Links: Pubmed | Publisher website

Ablation Specialist

Jafib
Powered by - Jafib Team   Privacy Policy | Site Map
hits counter